Funded Health Care Startups in Canada
In the 50 most recent Canada health care rounds shown, the largest disclosed amount is Prenuvo’s $120M on 2025-02-13, which dwarfs the rest of the disclose…
In the 50 most recent Canada health care rounds shown, the largest disclosed amount is Prenuvo’s $120M on 2025-02-13, which dwarfs the rest of the disclosed deals (the next-largest disclosed items are $46M on 2024-12-02 for VitalHub and $46M is followed by other large rounds like $28M for MolecuLight on 2025-01-06 and $27M for Fluid Biomed Inc. on 2024-12-16). Multiple clusters also appear: five disclosed rounds fall in August 2024 (e.g., Wisedocs $3M on 2024-08-01; Nova Leap Health $5M on 2024-11-26 is outside, but Aug includes Aplantex $2M on 2024-08-28, Unyte Health $4M on 2024-10-10 not in Aug; and Allied $500K on 2024-08-08), and Ontario-based companies recur repeatedly (e.g., Toronto for MedMe Health with an undisclosed round on 2025-08-20; Practice Better $13M on 2024-11-26; RetiSpec $10M on 2024-07-26). The time window runs from the most recent row on 2025-10-06 (Sonic Incytes, undisclosed) back to 2024-03-01 (Myomar Molecular, $810K), with a heavy disclosure gap as 20 of 50 rows are “Series Unknown” and 2 are “undisclosed”. Stage disclosure is also skewed toward late-stage capital signals in the disclosed set, including Series B ($120M Prenuvo) and multiple Series A deals such as Sound Blade Medical’s $17M (2025-01-29) and Acorn Biolabs’s $8M (2024-06-03).
Most recent rounds
50 shownRelated listings
Frequently asked
What stands out most in deal size across these Canada health care rounds, and how does it compare to other disclosed amounts?
Prenuvo’s disclosed $120M on 2025-02-13 is the clear outlier, far above other large disclosed rounds like VitalHub’s $46M on 2024-12-02 and MolecuLight’s $28M on 2025-01-06.
Do the rounds cluster in a specific time window or cadence within the 50-row slice?
Yes. Several sizable deals land in early 2025 and mid-2024: for example, 2025 includes $120M (Prenuvo, 2025-02-13), $17M (Sound Blade Medical, 2025-01-29), and $5M (Molecular You, 2025-08-20 is in Aug but another $5M exists via Leomed $3M on 2025-07-08); meanwhile June 2024 shows multiple entries such as Acorn Biolabs $8M on 2024-06-03 and Mesosil $2M on 2024-06-05.
Which geography appears over-represented in this list, and are there repeat hubs within Canada?
Ontario, especially Toronto, shows frequent appearances across months: MedMe Health (Toronto, undisclosed on 2025-08-20), Practice Better (Toronto, $13M on 2024-11-26), and RetiSpec (Toronto, $10M on 2024-07-26) illustrate a repeated Toronto pattern in otherwise widely distributed cities.
How much of the list lacks stage or amount disclosure, and does that affect the ability to compare deals directly?
Stage is often not specified: 20 of 50 rows are labeled “Series Unknown,” and 2 of 50 rows show “undisclosed” amounts (Sonic Incytes on 2025-10-06 and MedMe Health on 2025-08-20), limiting direct size comparisons for those entries.
Is the stage mix concentrated in a few labeled rounds, or does it look broad across stages?
It’s broad in labeling but still shows notable late-stage signals in the disclosed set: Series B appears via Prenuvo’s $120M (2025-02-13), while Series A appears multiple times with distinct sizes such as Sound Blade Medical $17M (2025-01-29) and Acorn Biolabs $8M (2024-06-03).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.